BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gheewala T, Skwor T, Munirathinam G. Photosensitizers in prostate cancer therapy. Oncotarget 2017;8:30524-38. [PMID: 28430624 DOI: 10.18632/oncotarget.15496] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Gheewala T, Skwor T, Munirathinam G. Photodynamic therapy using pheophorbide and 670 nm LEDs exhibits anti-cancer effects in-vitro in androgen dependent prostate cancer. Photodiagnosis and Photodynamic Therapy 2018;21:130-7. [DOI: 10.1016/j.pdpdt.2017.10.026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
2 Lange C, Lehmann C, Mahler M, Bednarski PJ. Comparison of Cellular Death Pathways after mTHPC-mediated Photodynamic Therapy (PDT) in Five Human Cancer Cell Lines. Cancers (Basel). 2019;11:pii: E702. [PMID: 31117328 DOI: 10.3390/cancers11050702] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
3 Wang L, Yang H, Li B. Photodynamic therapy for prostate cancer: a systematic review and meta-analysis. Prostate Int 2019;7:83-90. [PMID: 31485431 DOI: 10.1016/j.prnil.2018.12.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
4 Li X, Lovell JF, Yoon J, Chen X. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Rev Clin Oncol 2020;17:657-74. [DOI: 10.1038/s41571-020-0410-2] [Cited by in Crossref: 219] [Cited by in F6Publishing: 186] [Article Influence: 109.5] [Reference Citation Analysis]
5 Tracey AT, Nogueira LM, Alvim RG, Coleman JA, Murray KS. Focal therapy for primary and salvage prostate cancer treatment: a narrative review. Transl Androl Urol 2021;10:3144-54. [PMID: 34430417 DOI: 10.21037/tau-20-1212] [Reference Citation Analysis]
6 Öhrström L. Rounding up lutetium. Nature Chem 2018;10:372-372. [DOI: 10.1038/nchem.2938] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Karges J. Clinical Development of Metal Complexes as Photosensitizers for Photodynamic Therapy of Cancer. Angew Chem Int Ed Engl 2021. [PMID: 34748690 DOI: 10.1002/anie.202112236] [Reference Citation Analysis]
8 He Z, Yuan J, Shen F, Zeng F, Qi P, Wang Z, Zhai Z. Atorvastatin Enhances Effects of Radiotherapy on Prostate Cancer Cells and Xenograft Tumor Mice Through Triggering Interaction Between Bcl-2 and MSH2. Med Sci Monit 2020;26:e923560. [PMID: 32870824 DOI: 10.12659/MSM.923560] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Kirar S, Thakur NS, Reddy YN, Banerjee UC, Bhaumik J. Insights on the polypyrrole based nanoformulations for photodynamic therapy. J Porphyrins Phthalocyanines 2021;25:605-22. [DOI: 10.1142/s1088424621300032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Miyata Y, Mukae Y, Harada J, Matsuda T, Mitsunari K, Matsuo T, Ohba K, Sakai H. Pathological and Pharmacological Roles of Mitochondrial Reactive Oxygen Species in Malignant Neoplasms: Therapies Involving Chemical Compounds, Natural Products, and Photosensitizers. Molecules 2020;25:E5252. [PMID: 33187225 DOI: 10.3390/molecules25225252] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Owari T, Tanaka N, Nakai Y, Miyake M, Anai S, Kishi S, Mori S, Fujiwara-Tani R, Hojo Y, Mori T, Kuwada M, Fujii T, Hasegawa M, Fujimoto K, Kuniyasu H. 5-Aminolevulinic acid overcomes hypoxia-induced radiation resistance by enhancing mitochondrial reactive oxygen species production in prostate cancer cells. Br J Cancer 2022. [PMID: 35365766 DOI: 10.1038/s41416-022-01789-4] [Reference Citation Analysis]
12 McFarland SA, Mandel A, Dumoulin-White R, Gasser G. Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology? Curr Opin Chem Biol 2020;56:23-7. [PMID: 31759225 DOI: 10.1016/j.cbpa.2019.10.004] [Cited by in Crossref: 84] [Cited by in F6Publishing: 67] [Article Influence: 28.0] [Reference Citation Analysis]
13 Pavlíčková V, Jurášek M, Rimpelová S, Záruba K, Sedlák D, Šimková M, Kodr D, Staňková E, Fähnrich J, Rottnerová Z, Bartůněk P, Lapčík O, Drašar P, Ruml T. Oxime-based 19-nortestosterone-pheophorbide a conjugate: bimodal controlled release concept for PDT. J Mater Chem B 2019;7:5465-77. [PMID: 31414695 DOI: 10.1039/c9tb01301f] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Lin L, Wang LV. The emerging role of photoacoustic imaging in clinical oncology. Nat Rev Clin Oncol 2022. [PMID: 35322236 DOI: 10.1038/s41571-022-00615-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ferroni C, Del Rio A, Martini C, Manoni E, Varchi G. Light-Induced Therapies for Prostate Cancer Treatment. Front Chem 2019;7:719. [PMID: 31737599 DOI: 10.3389/fchem.2019.00719] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
16 Algorri JF, Ochoa M, Roldán-Varona P, Rodríguez-Cobo L, López-Higuera JM. Photodynamic Therapy: A Compendium of Latest Reviews. Cancers (Basel) 2021;13:4447. [PMID: 34503255 DOI: 10.3390/cancers13174447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 van Luijtelaar A, Fütterer JJ, Bomers JG. Minimally invasive magnetic resonance image-guided prostate interventions. Br J Radiol 2021;:20210698. [PMID: 34723623 DOI: 10.1259/bjr.20210698] [Reference Citation Analysis]
18 Zhang D, Lv P, Zhou C, Zhao Y, Liao X, Yang B. Cyclodextrin-based delivery systems for cancer treatment. Mater Sci Eng C Mater Biol Appl 2019;96:872-86. [PMID: 30606602 DOI: 10.1016/j.msec.2018.11.031] [Cited by in Crossref: 36] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
19 Güleryüz B, Ünal U, Gülsoy M. Near infrared light activated upconversion nanoparticles (UCNP) based photodynamic therapy of prostate cancers: An in vitro study. Photodiagnosis Photodyn Ther 2021;36:102616. [PMID: 34740839 DOI: 10.1016/j.pdpdt.2021.102616] [Reference Citation Analysis]
20 Miolo G, Sturaro G, Cigolini G, Menilli L, Tasso A, Zago I, Conconi MT. 4,6,4'-trimethylangelicin shows high anti-proliferative activity on DU145 cells under both UVA and blue light. Cell Prolif 2018;51:e12430. [PMID: 29318693 DOI: 10.1111/cpr.12430] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
21 Mesquita MQ, Ferreira AR, Neves MDGPMS, Ribeiro D, Fardilha M, Faustino MAF. Photodynamic therapy of prostate cancer using porphyrinic formulations. J Photochem Photobiol B 2021;223:112301. [PMID: 34492530 DOI: 10.1016/j.jphotobiol.2021.112301] [Reference Citation Analysis]
22 Yu X, Zheng H, Chan MTV, Wu WKK. Immune consequences induced by photodynamic therapy in non-melanoma skin cancers: a review. Environ Sci Pollut Res 2018;25:20569-74. [DOI: 10.1007/s11356-018-2426-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
23 Zhou S, Zhen Z, Paschall AV, Xue L, Yang X, Bebin Blackwell A, Cao Z, Zhang W, Wang M, Teng Y, Zhou G, Li Z, Avci FY, Tang W, Xie J. FAP‐Targeted Photodynamic Therapy Mediated by Ferritin Nanoparticles Elicits an Immune Response against Cancer Cells and Cancer Associated Fibroblasts. Adv Funct Mater 2021;31:2007017. [DOI: 10.1002/adfm.202007017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
24 Alejandro V, Mónica F, Xelha A, Mario R, Gabriel R, Norberto F, Eva R. Brominated BODIPYs as potential photosensitizers for photodynamic therapy using a low irradiance excitation. Polyhedron 2020;176:114207. [DOI: 10.1016/j.poly.2019.114207] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Yaqoob MD, Xu L, Li C, Leong MML, Xu DD. Targeting Mitochondria for Cancer Photodynamic Therapy. Photodiagnosis Photodyn Ther 2022;:102830. [PMID: 35341979 DOI: 10.1016/j.pdpdt.2022.102830] [Reference Citation Analysis]
26 Bendels MHK, Costrut AM, Schöffel N, Brüggmann D, Groneberg DA. Gendermetrics of cancer research: results from a global analysis on prostate cancer. Oncotarget 2018;9:19640-9. [PMID: 29731971 DOI: 10.18632/oncotarget.24716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
27 Wang ZY, Duan Y, Wang P. SP1-mediated upregulation of lncRNA SNHG4 functions as a ceRNA for miR-377 to facilitate prostate cancer progression through regulation of ZIC5. J Cell Physiol 2020;235:3916-27. [PMID: 31608997 DOI: 10.1002/jcp.29285] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
28 Xu DD, Xu CB, Lam HM, Wong FL, Leung AWN, Leong MML, Cho WCS, Hoeven R, Lv Q, Rong R. Proteomic analysis reveals that pheophorbide a-mediated photodynamic treatment inhibits prostate cancer growth by hampering GDP-GTP exchange of ras-family proteins. Photodiagnosis Photodyn Ther 2018;23:35-9. [PMID: 29800714 DOI: 10.1016/j.pdpdt.2018.05.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
29 Bui TL, Glavis-Bloom J, Chahine C, Mehta R, Wolfe T, Bhatter P, Rupasinghe M, Carbone J, Haider MA, Giganti F, Giona S, Oto A, Lee G, Houshyar R. Prostate minimally invasive procedures: complications and normal vs. abnormal findings on multiparametric magnetic resonance imaging (mpMRI). Abdom Radiol (NY) 2021;46:4388-400. [PMID: 33977352 DOI: 10.1007/s00261-021-03097-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Isaac-Lam MF, Hammonds DM. Synthesis and Photodynamic Activity of Vitamin-Chlorin Conjugates at Nanomolar Concentrations against Prostate Cancer Cells. ACS Omega 2019;4:21712-23. [PMID: 31891050 DOI: 10.1021/acsomega.9b02394] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
31 Masarapu H, Patel BK, Chariou PL, Hu H, Gulati NM, Carpenter BL, Ghiladi RA, Shukla S, Steinmetz NF. Physalis Mottle Virus-Like Particles as Nanocarriers for Imaging Reagents and Drugs. Biomacromolecules 2017;18:4141-53. [PMID: 29144726 DOI: 10.1021/acs.biomac.7b01196] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]
32 Patel P, Mathew MS, Trilisky I, Oto A. Multiparametric MR Imaging of the Prostate after Treatment of Prostate Cancer. RadioGraphics 2018;38:437-49. [DOI: 10.1148/rg.2018170147] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
33 Dias CJ, Sardo I, Moura NM, Felgueiras J, Neves MGP, Fardilha M, Faustino MAF. An efficient synthetic access to new uracil-alditols bearing a porphyrin unit and biological assessment in prostate cancer cells. Dyes and Pigments 2020;173:107996. [DOI: 10.1016/j.dyepig.2019.107996] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
34 Gunaydin G, Gedik ME, Ayan S. Photodynamic Therapy for the Treatment and Diagnosis of Cancer-A Review of the Current Clinical Status. Front Chem 2021;9:686303. [PMID: 34409014 DOI: 10.3389/fchem.2021.686303] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
35 Liu N, Liu H, Chen H, Wang G, Teng H, Chang Y. Polyphotosensitizer nanogels for GSH-responsive histone deacetylase inhibitors delivery and enhanced cancer photodynamic therapy. Colloids Surf B Biointerfaces 2020;188:110753. [PMID: 31884084 DOI: 10.1016/j.colsurfb.2019.110753] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
36 Li J, Hu ZE, Wei YJ, Zhou ZW, Liu YH, Wang N, Yu XQ. Novel amphiphilic fluorine-containing nanocarriers for oxygen self-sufficiency "AND" GSH depletion sequentially to enhance photodynamic therapy. Mater Sci Eng C Mater Biol Appl 2021;128:112341. [PMID: 34474891 DOI: 10.1016/j.msec.2021.112341] [Reference Citation Analysis]
37 Amendoeira A, García LR, Fernandes AR, Baptista PV. Light Irradiation of Gold Nanoparticles Toward Advanced Cancer Therapeutics. Adv Therap 2020;3:1900153. [DOI: 10.1002/adtp.201900153] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 4.7] [Reference Citation Analysis]
38 Akter S, Inai M, Saito S, Honda N, Hazama H, Nishikawa T, Kaneda Y, Awazu K. Photodynamic therapy by lysosomal-targeted drug delivery using talaporfin sodium incorporated into inactivated virus particles. Laser Ther 2019;28:245-56. [PMID: 32255916 DOI: 10.5978/islsm.19-OR-11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Carreño EA, Alberto AVP, de Souza CAM, de Mello HL, Henriques-pons A, Anastacio Alves L. Considerations and Technical Pitfalls in the Employment of the MTT Assay to Evaluate Photosensitizers for Photodynamic Therapy. Applied Sciences 2021;11:2603. [DOI: 10.3390/app11062603] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
40 Osuchowski M, Aebisher D, Bartusik-aebisher D, Krupka-olek M, Dynarowicz K, Przygoda M, Kawczyk-krupka A. Photodynamic Therapy-Adjunctive Therapy in the Treatment of Prostate Cancer. Diagnostics 2022;12:1113. [DOI: 10.3390/diagnostics12051113] [Reference Citation Analysis]
41 Razmienė B, Vojáčková V, Řezníčková E, Malina L, Dambrauskienė V, Kubala M, Bajgar R, Kolářová H, Žukauskaitė A, Arbačiauskienė E, Šačkus A, Kryštof V. Synthesis of N-aryl-2,6-diphenyl-2H-pyrazolo[4,3-c]pyridin-7-amines and their photodynamic properties in the human skin melanoma cell line G361. Bioorg Chem 2021;119:105570. [PMID: 34953323 DOI: 10.1016/j.bioorg.2021.105570] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Bolitho EM, Sanchez-Cano C, Huang H, Hands-Portman I, Spink M, Quinn PD, Harkiolaki M, Sadler PJ. X-ray tomography of cryopreserved human prostate cancer cells: mitochondrial targeting by an organoiridium photosensitiser. J Biol Inorg Chem 2020;25:295-303. [PMID: 32124100 DOI: 10.1007/s00775-020-01761-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
43 Pratavieira S, Uliana MP, Dos Santos Lopes NS, Donatoni MC, Linares DR, de Freitas Anibal F, de Oliveira KT, Kurachi C, de Souza CWO. Photodynamic therapy with a new bacteriochlorin derivative: Characterization and in vitro studies. Photodiagnosis Photodyn Ther 2021;34:102251. [PMID: 33705980 DOI: 10.1016/j.pdpdt.2021.102251] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Oliveira P, Lopes T, Tedesco A, Rahal P, Calmon M. Effect of berberine associated with photodynamic therapy in cell lines. Photodiagnosis and Photodynamic Therapy 2020;32:102045. [DOI: 10.1016/j.pdpdt.2020.102045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
45 Song C, Xu W, Wu H, Wang X, Gong Q, Liu C, Liu J, Zhou L. Photodynamic therapy induces autophagy-mediated cell death in human colorectal cancer cells via activation of the ROS/JNK signaling pathway. Cell Death Dis 2020;11:938. [PMID: 33130826 DOI: 10.1038/s41419-020-03136-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
46 Koch G, Cazzato RL, Caudrelier J, Cathelineau X, Lang H, Gangi A. [Image-guided tumor ablation]. Prog Urol 2017;27:853-64. [PMID: 28864163 DOI: 10.1016/j.purol.2017.07.244] [Reference Citation Analysis]
47 James NS, Cheruku RR, Missert JR, Sunar U, Pandey RK. Measurement of Cyanine Dye Photobleaching in Photosensitizer Cyanine Dye Conjugates Could Help in Optimizing Light Dosimetry for Improved Photodynamic Therapy of Cancer. Molecules 2018;23:E1842. [PMID: 30042350 DOI: 10.3390/molecules23081842] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
48 Jethva P, Momin M, Khan T, Omri A. Lanthanide-Doped Upconversion Luminescent Nanoparticles-Evolving Role in Bioimaging, Biosensing, and Drug Delivery. Materials (Basel) 2022;15:2374. [PMID: 35407706 DOI: 10.3390/ma15072374] [Reference Citation Analysis]
49 Deng Y, Zhang Q, Liu G, Lin T, Zhang W, He X, Lu W, Ding Y, Cao W, Guo H, Shi D. Self-Assembled PSMA-Targeted Nanoparticles Enhanced Photodynamic Therapy in Prostate Cancer. Journal of Nanomaterials 2022;2022:1-12. [DOI: 10.1155/2022/8726662] [Reference Citation Analysis]